Schizophrenia Research
Volume 118, Issue 1 , Pages 201-210 , May 2010

Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizophrenia: A systematic meta-review

  • S.L. Matheson

      Affiliations

    • Schizophrenia Research Institute, 405 Liverpool St, Darlinghurst, NSW 2031, Australia
    • School of Psychiatry, University of New South Wales, Randwick, NSW 2031, Australia
    • Corresponding Author InformationCorresponding author. c/- CRUfAD UNSW at St Vincent's Hospital, 299 Forbes St, Darlinghurst NSW 2010, Australia. Tel.: +61 2 8382 1878, +61 413 340 307 (Mob); fax: +61 2 8382 1721.
    • ,
  • M.J. Green

      Affiliations

    • School of Psychiatry, University of New South Wales, Randwick, NSW 2031, Australia
    • Black Dog Institute, Hospital Road, Prince of Wales Hospital, Randwick, NSW 2031, Australia
    • ,
  • C. Loo

      Affiliations

    • School of Psychiatry, University of New South Wales, Randwick, NSW 2031, Australia
    • Black Dog Institute, Hospital Road, Prince of Wales Hospital, Randwick, NSW 2031, Australia
    • St George Hospital, Kogarah, NSW 2217, Australia
    • ,
  • V.J. Carr

      Affiliations

    • Schizophrenia Research Institute, 405 Liverpool St, Darlinghurst, NSW 2031, Australia
    • School of Psychiatry, University of New South Wales, Randwick, NSW 2031, Australia

Received 28 July 2009 ,Revised 11 January 2010 ,Accepted 13 January 2010.

References 

  1. Aleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. Journal of Clinical Psychiatry. 2007;68(3):416–421
  2. American Psychiatric Association . Treatment of Patients With Schizophrenia. Second Edition. 2004;
  3. Braga RJ, Petrides G. The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia. Journal of ECT. 2005;21(2):75–83
  4. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. International Journal of Neuropsychopharmacology. 2002;5(1):73–103
  5. Chanpattana W, Andrade C. ECT for treatment-resistant schizophrenia: a response from the far East to the UK. NICE report. Journal of ECT. 2006;22(1):4–12
  6. Chung Y, Im E, Cho G, Ko M. Second run of transcranial magnetic stimulation has no effects on persistent auditory hallucinations. World Journal of Biological Psychiatry. 2007;8(1):48–50
  7. Cordes J, Arends M, Mobascher A, Brinkmeyer J, Kornischka J, Eichhammer P, et al. Potential clinical targets of repetitive transcranial magnetic stimulation treatment in schizophrenia. Neuropsychobiology. 2006;54(2):87–99
  8. Fitzgerald PB, Benitez J, Daskalakis JZ, De Castella A, Kulkarni J. The treatment of recurring auditory hallucinations in schizophrenia with rTMS. World Journal of Biological Psychiatry. 2006;7(2):119–122
  9. Fitzgerald PB, Daskalakis ZJ. A review of repetitive transcranial magnetic stimulation use in the treatment of schizophrenia. Canadian Journal of Psychiatry — Revue Canadienne de Psychiatrie. 2008;53(9):567–576
  10. Freitas C, Fregni F, Pascual-Leone A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophrenia Research. 2009;108(1–3):11–24
  11. Gazdag G, Kocsis N, Lipcsey A. Rates of electroconvulsive therapy use in Hungary in 2002. Journal of ECT. 2004;20(1):42–44
  12. GRADE Working Group . Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490
  13. GRADEpro. (Computer program). Version 3.2 for Windows. Jan Brozek, Andrew Oxman, Holger Schünemann, 2008.
  14. Greenhalgh J, Knight C, Hind D, Beverley C, Walters S. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies. Health Technology Assessment. 2005;9(9):1–156
  15. Haraldsson HM, Ferrarelli F, Kalin NH, Tononi G. Transcranial Magnetic Stimulation in the investigation and treatment of schizophrenia: a review. Schizophrenia Research. 2004;71(1):1–16
  16. Havaki-Kontaxaki BJ, Ferentinos PP, Kontaxakis VP, Paplos KG, Soldatos CR. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia. Clinical Neuropharmacology. 2006;29(1):52–56
  17. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration. Version 5.0.1. 2008;
  18. Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, et al. Combined electroconvulsive-clozapine therapy. Clinical Neuropharmacology. 2000;23(1):14–16
  19. Lopez-Ibor JJ, Lopez-Ibor MI, Pastrana JI. Transcranial magnetic stimulation. Current Opinion in Psychiatry. 2008;21(6):640–644
  20. Machii K, Cohen D, Ramos-Estebanez C, Pascual-Leone A. Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clinical Neurophysiology. 2006;117(2):455–471
  21. Malhi GS, Sachdev P. Novel physical treatments for the management of neuropsychiatric disorders. Journal of Psychosomatic Research. 2002;53(2):709–719
  22. Malhi GS, Loo C, Cahill CM, Lagopoulos J, Mitchell P, Sachdev P. “Getting physical”: the management of neuropsychiatric disorders using novel physical treatments. Neuropsychiatric Disease and Treatment. 2006;2(2):165–179
  23. McNamara B, Ray JL, Arthurs OJ, Boniface S. Transcranial magnetic stimulation for depression and other psychiatric disorders. Psychological Medicine. 2001;31(7):1141–1146
  24. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF for the QUOROM Group. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet. 1999;354:1896–1900
  25. Painuly N, Chakrabarti S. Combined use of electroconvulsive therapy and antipsychotics in schizophrenia: the Indian evidence. A review and a meta-analysis. Journal of ECT. 2006;22(1):59–66
  26. Reid P, Shajahan P, Glabus M, Ebmeier K. Transcranial magnetic stimulation in depression. British Journal of Psychiatry. 1998;173:449–452
  27. Rodriguez-Martin J, Barbanoj J, Schlaepfer T, Clos S, Pérez V, Kulisevsky J, et al. Transcranial magnetic stimulation for treating depression. Cochrane Database of Systematic Reviews. 2001;(4):
  28. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database of Systematic Reviews. 2005;2:CD000076
  29. The UK ECT Review Group . Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361(9360):799–808
  30. Tranulis C, Sepehry AA, Galinowski A, Stip E. Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A metaanalysis. Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie. 2008;53(9):577–586
  31. Walter G, Tormos JM, Israel JA, Pascual-Leone A. Transcranial magnetic stimulation in young persons: a review of known cases. Journal of Child and Adolescent Psychopharmacology. 2001;11(1):69–75

PII: S0920-9964(10)00040-X

doi: 10.1016/j.schres.2010.01.002

Schizophrenia Research
Volume 118, Issue 1 , Pages 201-210 , May 2010

Article Tools

* Image Usage & Resolution